MAPT and Alzheimer disease: Glial fibrillary acidic protein (GFAP) in blood has also shown changes in some non‐AD pathologies30, 31 but recent data have clearly demonstrated its dynamic change in response to amyloid and tau deposition.32, 33, 34, 35